相似文献
1
Asymptomatic malignant pleural effusion: to observe or to manage.
J Thorac Dis. 2017 Sep;9(Suppl 10):S1146-S1147. doi: 10.21037/jtd.2017.06.52.
2
Managing malignant pleural effusion with an indwelling pleural catheter: factors associated with spontaneous pleurodesis.
Hong Kong Med J. 2016 Aug;22(4):334-40. doi: 10.12809/hkmj154673. Epub 2016 Jun 3.
3
Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study.
Thorac Cancer. 2019 Oct;10(10):1885-1892. doi: 10.1111/1759-7714.13158. Epub 2019 Aug 6.
4
Malignant melanoma presenting as an isolated pleural effusion.
Monaldi Arch Chest Dis. 2011 Jun;75(2):138-40. doi: 10.4081/monaldi.2011.228.
5
Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion.
Chest. 2003 Apr;123(4):1188-95. doi: 10.1378/chest.123.4.1188.
6
CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.
Am J Respir Crit Care Med. 2005 Dec 1;172(11):1434-9. doi: 10.1164/rccm.200504-588OC. Epub 2005 Sep 8.
7
Pleural effusion in an asymptomatic patient. Spectrum and frequency of causes and management considerations.
Chest. 1990 Jan;97(1):192-6. doi: 10.1378/chest.97.1.192.
8
Indwelling pleural catheters for malignant pleural effusion.
Int J Palliat Nurs. 2015 Jun;21(6):266, 268-70. doi: 10.12968/ijpn.2015.21.6.266.
9
Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions.
AJR Am J Roentgenol. 1998 Apr;170(4):943-6. doi: 10.2214/ajr.170.4.9530040.
10
Malignant pleural diseases.
Monaldi Arch Chest Dis. 2000 Feb;55(1):17-9.
引用本文的文献
1
A Rapidly Enlarging Asymptomatic Parapneumonic Effusion: A Case Report.
Cureus. 2024 Jan 26;16(1):e52986. doi: 10.7759/cureus.52986. eCollection 2024 Jan.
2
Malignant Pleural Effusions: Updates in Diagnosis and Management.
Life (Basel). 2022 Dec 31;13(1):115. doi: 10.3390/life13010115.
3
Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.
J Cardiothorac Surg. 2021 May 4;16(1):125. doi: 10.1186/s13019-021-01475-1.
4
Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis.
Gen Thorac Cardiovasc Surg. 2021 May;69(5):832-842. doi: 10.1007/s11748-020-01549-2. Epub 2020 Nov 22.
本文引用的文献
1
Comparing approaches to the management of malignant pleural effusions.
Expert Rev Respir Med. 2017 Apr;11(4):273-284. doi: 10.1080/17476348.2017.1300532. Epub 2017 Mar 8.
2
Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions.
J Thorac Dis. 2015 Jun;7(6):1052-7. doi: 10.3978/j.issn.2072-1439.2015.01.51.
3
Malignant pleural effusions: a review.
Clin Chest Med. 2013 Sep;34(3):459-71. doi: 10.1016/j.ccm.2013.05.004. Epub 2013 Jul 23.
4
Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion.
Support Care Cancer. 2013 Nov;21(11):3109-16. doi: 10.1007/s00520-013-1895-3. Epub 2013 Jul 11.
5
Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.
Thorax. 2010 Aug;65 Suppl 2:ii32-40. doi: 10.1136/thx.2010.136994.
6
Emerging paradigms in the management of malignant pleural effusions.
Respir Med. 2008 Jul;102(7):939-48. doi: 10.1016/j.rmed.2008.01.022. Epub 2008 Mar 19.
7
Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer.
Int J Cancer. 2006 Nov 15;119(10):2353-8. doi: 10.1002/ijc.22190.
8
Effects of pleural effusion on respiratory function.
Can Respir J. 2004 Oct;11(7):499-503. doi: 10.1155/2004/496901.
9
Management of malignant pleural effusions.
Respirology. 2004 Jun;9(2):148-56. doi: 10.1111/j.1440-1843.2004.00566.x.
10
Management of malignant pleural effusions.
Am J Respir Crit Care Med. 2000 Nov;162(5):1987-2001. doi: 10.1164/ajrccm.162.5.ats8-00.
Zotero 插件